KISUMU, 18 July 2014 (IRIN) - Kenya is experimenting with unconventional methods to tackle high malaria rates through the piloting of mass drug administration (MDA) - treating entire communities with anti-malarial drugs, regardless of whether they have the parasite. 

The project is an initiative of the newly created Malaria Elimination Consortium of Western Kenya, founded in 2013 by the US Centers for Disease Control (CDC), Kenya Medical Research Institute (KEMRI), and other partners, an...


This story is part of New Europe's Premium content.

To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑
new europe join now